Literature DB >> 11261335

[Epidemiology-etiology of dilated cardiomyopathy].

H G Olbrich1.   

Abstract

Among the cardiomyopathies,--dilated cardiomyopathy (dcm), hypertrophic cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy--, dcm is the most frequent entity. Its prevalence in the United States amounts to 36 cases per 100,000 inhabitants, men being almost 3-fold more involved than women. The etiology of dcm is very heterogenous; 50% of the cases are due to idiopathic dcm whereas the other half comprises a broad spectrum of various etiologies such as myocarditis, ischemic heart disease, peripartal cardiomyopathy, hypertension, HIV infection, toxic cardiomyopathy and others. In 20 to 30% of the cases of idiopathic dcm a genetic transmission of the disease has been found. Another 20 to 30% of idiopathic dcm are associated with inflammatory and immunological phenomena. Infectious myocarditis with enteroviruses, especially with coxsackie-virus type B has been suggested to be an important trigger for an immune-mediated dcm. In both, familiar dcm and infection with coxsackie-virus B, an impairment of constituents of the myocardial cytoskeleton has been shown. This is regarded as a possible pathogenetic mechanism in the development of dcm.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11261335     DOI: 10.1007/s003920170052

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  7 in total

1.  Novel mutations in beta-myosin heavy chain, actin and troponin-I genes associated with dilated cardiomyopathy in Indian population.

Authors:  Ushasree Boda; Shivani Vadapalli; Narsimhan Calambur; Pratibha Nallari
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

Review 2.  Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.

Authors:  Rui Guo; Sreejayan Nair
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-24       Impact factor: 5.187

Review 3.  Diagnostics of messenger ribonucleic acid (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) vaccination-associated myocarditis-A systematic review.

Authors:  Jan M Federspiel; Frank Ramsthaler; Mattias Kettner; Gerhard Mall
Journal:  Rechtsmedizin (Berl)       Date:  2022-07-20       Impact factor: 1.112

Review 4.  The MOGE(S) classification for cardiomyopathies: current status and future outlook.

Authors:  Julian G Westphal; Angelos G Rigopoulos; Constantinos Bakogiannis; Sarah E Ludwig; Sophie Mavrogeni; Boris Bigalke; Torsten Doenst; Matthias Pauschinger; Carsten Tschöpe; P Christian Schulze; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

5.  Cost-effectiveness of pre-participation screening of athletes with ECG in Europe and Algeria.

Authors:  Deodato Assanelli; Rosella Levaggi; François Carré; Sanjay Sharma; Asterios Deligiannis; Klaus Peter Mellwig; Mohamed Tahmi; Giovanni Vinetti; Paola Aliverti
Journal:  Intern Emerg Med       Date:  2014-08-28       Impact factor: 3.397

Review 6.  Viral myocarditis: diagnosis, aetiology and management.

Authors:  Uwe Kühl; Heinz-Peter Schultheiss
Journal:  Drugs       Date:  2009-07-09       Impact factor: 9.546

Review 7.  Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance.

Authors:  Marco Francone
Journal:  ISRN Radiol       Date:  2014-02-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.